Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19

Overview of attention for article published in Drug Design, Development and Therapy, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

patent: 2 patents
peer_reviews: 1 peer review site

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Patents Peer reviews Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MONOCLONAL ANTIBODY USED AGAINST VARIOUS CORONAVIRUSES AND APPLICATION THEREOF

Application WO-2022083675-A1

World Intellectual Property Organisation (WIPO)

EMULSOMES COMPRISING S-LAYER FUSION PROTEINS AND METHODS OF USE THEREOF

Application WO-2022031376-A1

World Intellectual Property Organisation (WIPO)